Wednesday, October 23, 2019

Alembic Pharma gets USFDA nod for Desonide Ointment

Alembic Pharma gets USFDA nod for Desonide Ointment Desonide Ointment, 0.05 per cent, is a low potency corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses, Alembic Pharmaceuticals sad in a BSE filing.

from Moneycontrol Business News https://ift.tt/31Ja58u
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Madhu Kela picks up stake in this stock market proxy player in Q3

Veteran investor Madhu Kela has bought a stake in Emkay Global. This signals new interest in the financial services firm. Ace investor Dolly...